Photo of Julie Brahmer taken from Stephen Liu/X
Mar 5, 2024, 12:21
Stephen Liu: In 2012, Dr. Julie Brahmer presented the phase I study of immunotherapy in lung cancer
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown Lombardi, recently shared on X/Twitter:
“In 2012, Dr. Julie Brahmer presented data from the phase I study of nivolumab showing durable responses to immunotherapy in lung cancer. Hear the story behind the trial in tomorrow’s special episode of Lung Cancer Considered, the IASLC podcast, with me and Dr. Narjust Florez.”
Source: Stephen Liu/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46